Michael Stromquist
Lawyers
Filters
Esperion Therapeutics follow-on offering
The shares are listed on Nasdaq
Strive acquisition of Semler Scientific
We are advising Strive on the acquisition
Norwegian Cruise Line Holdings comprehensive refinancing transactions
The transactions included new debt, exchangeable debt, registered direct equity offerings and concurrent tender offers
Bombardier $250 million senior notes offering
The investment-grade senior notes are due 2033
Strive Nasdaq listing and $450 million at-the-market offering
We advised Strive on its Nasdaq listing and offering
DICK’S Sporting Goods exchange offer
The exchange offer included the issuance of new senior notes due 2029
JBT Marel $575 million convertible senior notes offering
The 0.375% convertible senior notes are due 2030
StoneX Group $625 million senior secured notes offering
We advised StoneX on the high-yield notes offering
Life Time $588 million secondary offering
The shares are listed on the New York Stock Exchange
Bombardier $500 million senior notes offering
The investment-grade senior notes are due 2033